Prognostic role of prostate specific antigen kinetics in primary high volume metastatic hormonal sensitive prostate cancer treated with novel hormonal therapy agents
Yingchun Wang, Jie Suo, Bo Wang, Qunli Men, Dachuan Wang, Haibo Jing, Tao Li, Xiaodong Huang, Chenqing Wang, Xiaohui Luo, Yuquan Ju, Junjie Fan, Jianzhou Liu · 2024
Read Prognostic role of prostate specific antigen kinetics in primary high volume metastatic hormonal sensitive prostate cancer treated with novel hormonal therapy agents by Yingchun Wang, Jie Suo, Bo Wang, Qunli Men, Dachuan Wang, Haibo Jing, Tao Li, Xiaodong Huang, Chenqing Wang, Xiaohui Luo, Yuquan Ju, Junjie Fan, Jianzhou Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11535213.txt.
Description
Yingchun Wang and a large team of doctors study prostate cancer markers in this two thousand twenty-four paper. Their patients had hormone-sensitive prostate cancer that had spread widely at first diagnosis. All were treated with newer hormonal drugs. The team asked whether the path of PSA, a blood marker, predicts how patients fare. They reviewed the records of one hundred two patients.
Follow-up lasted about thirty-two months on average. The lowest PSA after treatment, and the PSA density at three months, both carried signal. Patients whose lowest PSA fell to a low level did better. So did those with low PSA density early on. The lack of spread to inner organs also helped. The authors say simple PSA measures can flag which patients need closer watch or stronger care.
Catalog record
| CREATOR | Yingchun Wang, Jie Suo, Bo Wang, Qunli Men, Dachuan Wang, Haibo Jing, Tao Li, Xiaodong Huang, Chenqing Wang, Xiaohui Luo, Yuquan Ju, Junjie Fan, Jianzhou Liu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |